Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: First results from the ARG-E03 trial

被引:35
作者
Koster, Andreas
Buz, Semi
Hetzer, Roland
Kuppe, Hermann
Breddin, Klaus
Harder, Sebastian
机构
[1] Deutsch Herzzentrum Berlin, Dept Anesthesia, D-13353 Berlin, Germany
[2] Deutsch Herzzentrum Berlin, Dept Cardiothorac & Vasc Surg, D-13353 Berlin, Germany
[3] Int Inst Thrombosis & Vasc Dis, Frankfurt, Germany
[4] Univ Frankfurt Klinikum, Dept Clin Pharmacol, D-6000 Frankfurt, Germany
关键词
THERAPY;
D O I
10.1016/j.jtcvs.2006.04.034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:699 / 700
页数:2
相关论文
共 5 条
[1]   Drug therapy -: Direct thrombin inhibitors [J].
Di Nisio, M ;
Middeldorp, S ;
Büller, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) :1028-1040
[2]   Effect of argatroban on the activated partial thromboplastin time: a comparison of 21 commercial reagents [J].
Francis, JL ;
Hursting, MJ .
BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (04) :251-257
[3]   Argatroban anticoagulation in patients with heparin-induced thrombocytopenia [J].
Lewis, BE ;
Wallis, DE ;
Leya, F ;
Hursting, MJ ;
Kelton, JG .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (15) :1849-1856
[4]  
Lewis BE, 2001, CIRCULATION, V103, P1838
[5]   Excessive argatroban anticoagulation for heparin-induced thrombocytopenia [J].
Reichert, MG ;
MacGregor, DA ;
Kincaid, EH ;
Dolinski, SY .
ANNALS OF PHARMACOTHERAPY, 2003, 37 (05) :652-654